Rhythm Pharmaceuticals (RYTM) Current Leases (2019 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Current Leases of $676000.0 for Q1 2026, up 201.79% year-over-year from $224000.0 in Q1 2025, and up 4.0% quarter-over-quarter from $650000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Current Leases (2019 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 8 years of Current Leases data on file, last reported at $676000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $676000.0, up 201.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $676000.0 (up 201.79% YoY), and the FY2025 annual result was $650000.0, changed N/A from the prior year.
- Current Leases climbed to $676000.0 in Q1 2026 per RYTM's latest filing, from $650000.0 in the prior quarter.
- Over five years, Current Leases peaked at $816000.0 in Q2 2024 and troughed at $224000.0 in Q1 2025.
- A 5-year average of $657266.7 and a median of $676000.0 in 2026 frame the typical range for Current Leases.
- The sharpest annual moves came in 2025 and 2026: Current Leases tumbled 71.75% in 2025, then soared 201.79% in 2026.
- A 5-year view of Current Leases shows it stood at $684000.0 in 2022, then rose by 12.57% to $770000.0 in 2023, then advanced by 5.97% to $816000.0 in 2024, then declined by 20.34% to $650000.0 in 2025, then gained by 4.0% to $676000.0 in 2026.
- Business Quant data shows RYTM's Current Leases at $676000.0 in Q1 2026, $650000.0 in Q4 2025, and $624000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | 676,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 676,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 624,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | 224,000.00 |
| Jun 30, 2024 | 816,000.00 |
| Mar 31, 2024 | 793,000.00 |
| Dec 31, 2023 | 770,000.00 |
| Sep 30, 2023 | 748,000.00 |
| Jun 30, 2023 | 726,000.00 |
| Mar 31, 2023 | 705,000.00 |
| Dec 31, 2022 | 684,000.00 |
| Sep 30, 2022 | 664,000.00 |
| Jun 30, 2022 | 644,000.00 |
| Mar 31, 2022 | 625,000.00 |
| Dec 31, 2021 | 606,000.00 |
| Sep 30, 2021 | 588,000.00 |
| Jun 30, 2021 | 570,000.00 |
| Mar 31, 2021 | 553,000.00 |
| Dec 31, 2020 | 535,000.00 |